This is a presentation of a research paper which explores both current guidelines and recent research on the use of angiotensin converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) in the prevention and treatment of diabetic nephropathy in patients with type II diabetes mellitus. The purpose of this paper was to review current literature in order to determine the effectiveness of dual therapy with an ACE and an ARB. These medications and their effects on proteinuria were examined closely in patients, especially in regards to safety. The review of literature provides an extensive overview of the dual use of ACEI and ARB’s in the prevention of diabetic nephropathy.
Keywords: Angiotensin II Type I Receptor Blockers, Angiotensin-Converting Enzyme Inhibitors, Type II Diabetes Mellitus, and Diabetic Nephropathy
This is a metadata-only record.
- Event location
- Event date
4 April 2013
- Date submitted
18 July 2022
- Additional information
Toni Barnett PhD, APRN, BC FNP-C, CNE